UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NVCR — NovoCure Ltd
CIK 861177
NEW YORK, NY
Position in NVCR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,488,127
-$440,514 QoQ
Shares Held
228,269
+0.8% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 51.076142621205676.ToString("F0")%
Shared 0.ToString("F0")%
None 48.92385737879432.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $6,140,526,672 across 63 Medical Devices names. NVCR ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
13,198,740 | $1,355,114,632 | |
| 2 | BSX |
Boston Scientific Corp
|
13,513,771 | $847,989,125 | |
| 3 | MDT |
Medtronic plc
|
9,733,748 | $843,429,259 | |
| 4 | SYK |
Stryker Corp
|
2,208,201 | $725,592,760 | |
| 5 | DXCM |
Dexcom Inc
|
9,746,174 | $612,059,721 | |
| 6 | EW |
Edwards Lifesciences Corp
|
5,458,148 | $437,088,487 | |
| 7 | STE |
STERIS plc
|
1,253,502 | $277,186,892 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
2,521,213 | $179,459,935 |
All Filings in NVCR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,488,127 | 228,269 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,928,641 | 226,500 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $15,447,459 | 1,195,624 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,413,248 | 1,371,531 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $31,758,068 | 1,782,159 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $20,909,017 | 701,645 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $14,192,021 | 907,999 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $14,104,721 | 823,393 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,108,218 | 134,883 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,924,057 | 128,872 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,919,102 | 118,830 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $17,697,175 | 426,438 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $25,645,976 | 426,438 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $31,861,768 | 434,380 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $30,793,017 | 405,278 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,941,988 | 430,820 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $25,869,326 | 312,243 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,571,501 | 327,271 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,565,781 | 314,761 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $69,655,024 | 314,016 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $37,395,039 | 282,910 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $38,463,156 | 222,279 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $12,228,291 | 109,858 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,927,387 | 99,956 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,754,460 | 219,104 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||